Skip to content

Effects of acupuncture on prehypertension and stage1 hypertension: a pilot randomized controlled trial

Effects of acupuncture on prehypertension and stage 1 hypertension: a pilot randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0000496
Enrollment
30
Registered
2012-08-02
Start date
2012-07-09
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Treatment group (acupuncture group): acupuncture treatment twice per week, for 8 weeks Control group (un-treated group): un-treated, maintain a usual lifestyle throughout the study

Sponsors

Korea Institute of Oriental Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Male or female over 20 and under 65 years of age with hypertension 2. pre and stage I hypertension according to JNC 7(essential hypertension,SBP:120-159mmHg or DBP:80-99mmHg) 3. patients voluntarily participated in this trial and singed consent form

Exclusion criteria

Exclusion criteria: 1. those who are taking prescriptions or OTC medications or herb/supplements in order to control their blood pressure in the past 6 months 2. second stage hypertension patients 3. personal history, such as cerebrovascular diseases and cardiovascular diseases(myocardial infarction, angina pectoris, valvular heart disease, etc.) 4. history of vicious tumor 5. diabetic patients taking insulin or anti-diabetic medications 6. those with history of kidney, liver, thyroid gland diseases 7. those with hemorrhagic diseases or taking anticoagulation medications(excluding aspirin) 8. those dependent on drugs or addicted to alcohol 9. those with active tuberculosis or other infectious diseases 10. those who have had hypersensivity reactions following acupuncture 11. those who are receiving systemic steroid therapy or immunosuppressive drug therapy 12. those who have taken drugs that affect blood pressure in the past week or who have been taking them for a while, such as oral birth control pills, central nervous system depressants, or stimulants 13. pregnant mothers, lactating woman and those planning for pregnancy 14. those who have received oriental medicine treatment related to hypertension in the past one month 15. those who are deemed not to be suitable as judged by the person in charge of carrying out the clinical trial

Design outcomes

Primary

MeasureTime frame
differences in mean SBP and DBP values between groups

Secondary

MeasureTime frame
differences in mean SBP and DBP values between groups;lipid profile(Total Cholesterol, HDL, LDL, Triglyceride);BMI(Body rate variability);HRV(Heart Rate Variability);Health Status Questionnaire(EQ-5D)

Countries

Korea, Republic of

Contacts

Public ContactYan Liu

Korea Institute of Oriental Medicine

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Mar 4, 2026